SIGHT SCIENCES, INC.
Surgical & Medical Instruments & Apparatus- 売上
- $77m
- 時価総額
- $284m
株価 $5.30 · 100株 530円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $81m | $80m | $77m |
| 成長率 | — | ▲1.5% | ▲3.1% |
| 総利益 | $69m | $68m | $67m |
| 総利益率 | 85.3% | 85.5% | 86.2% |
| 販管費 | $109m | $101m | $89m |
| 販管費率 | 134.3% | 126.2% | 115.2% |
| 営利 | ▲$57m | ▲$51m | ▲$37m |
| 営利率 | ▲70.7% | ▲63.3% | ▲48.0% |
| 純利益 | ▲$56m | ▲$52m | ▲$38m |
| PBR | 2.4 | 3.2 | 4.4 |
| PSR | 3.5 | 3.5 | 3.7 |
| PGPR | 4.1 | 4.2 | 4.3 |
| PER | — | — | — |
| ネットキャッシュ | $104m | $81m | $52m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲65% | ▲51% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
